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Introduction: The aim of this study was to test the naturally occurring organosulfur compound dipropyltetrasulfide
(DPTTS), found in plants, which has antibiotic and anticancer properties, as a treatment for HOCl-induced systemic
sclerosis in the mouse.
Methods: The prooxidative, antiproliferative, and cytotoxic effects of DPTTS were evaluated ex vivo on fibroblasts
from normal and HOCl mice. In vivo, the antifibrotic and immunomodulating properties of DPTTS were evaluated in
the skin and lungs of HOCl mice.
Results: H2O2 production was higher in fibroblasts derived from HOCl mice than in normal fibroblasts (P < 0.05).
DPTTS did not increase H2O2 production in normal fibroblasts, but DPTTS dose-dependently increased H2O2
production in HOCl fibroblasts (P < 0.001 with 40 μM DPTTS). Because H2O2 reached a lethal threshold in cells from
HOCl mice, the antiproliferative, cytotoxic, and proapoptotic effects of DPTTS were significantly higher in HOCl
fibroblasts than for normal fibroblasts. In vivo, DPTTS decreased dermal thickness (P < 0.001), collagen content in skin
(P < 0.01) and lungs (P < 0.05), αSMA (P < 0.01) and pSMAD2/3 (P < 0.01) expression in skin, formation of advanced
oxidation protein products and anti-DNA topoisomerase-1 antibodies in serum (P < 0.05) versus untreated HOCl
mice. Moreover, in HOCl mice, DPTTS reduced splenic B-cell counts (P < 0.01), the proliferative rates of B-splenocytes
stimulated by lipopolysaccharide (P < 0.05), and T-splenocytes stimulated by anti-CD3/CD28 mAb (P < 0.001). Ex vivo,
it also reduced the production of IL-4 and IL-13 by activated T cells (P < 0.05 in both cases).
Conclusions: The natural organosulfur compound DPTTS prevents skin and lung fibrosis in the mouse through the
selective killing of diseased fibroblasts and its immunomodulating properties. DPTTS may be a potential treatment
for systemic sclerosis.Introduction
Systemic sclerosis is a connective tissue disease charac-
terized by fibrosis of skin and visceral organs, vascular
disorders, and dysimmunity [1]. Although the pathogen-
esis of systemic sclerosis is not fully understood, recent
data suggested that oxidative stress and inflammation
play an important role in the initiation and development
of this disease [2-4]. At an early stage of systemic scler-
osis, activated fibroblasts constitutively produce high* Correspondence: frederic.batteux@cch.aphp.fr.
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reproduction in any medium, provided the oramounts of reactive oxygen species (ROS) that cause the
synthesis of type I collagen and lead to fibrosis [3]. The
release of highly toxic ROS by activated fibroblasts and
endothelial cells induces an inflammatory process that
triggers the recruitment of inflammatory cells, the pro-
duction of cytokines, and increases the fibrotic process
[5] through the involvement of the RAS/MAP kinase
pathways [6]. In our mouse model of systemic sclerosis
(induced by HOCl), an activated phenotype, an overpro-
duction of ROS, and a drop in the content of reduced
glutathione are observed in diseased fibroblasts (3, 14).
The involvement of the immune system in the pathogen-
esis of SSc is also reflected by circulating auto-antibodies,
such as anti-DNA topoisomerase-1 antibodies (Abs) thattd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of tolerance caused by oxidized DNA topoisomerase-1 [7].
Auto-abs against platelet-derived growth factor receptor
are also found in SSc, that trigger the production of ROS
and can play a role in the perpetuation of the disease. If
intracellular ROS can stimulate cell growth and fibrosis,
ROS can also lead to cell death beyond a certain level of
intracellular production. ROS generating molecules such as
arsenic trioxide can kill fibroblasts in constitutively acti-
vated SSc, thus abrogating the development of fibrosis in
two mouse models of SSc. However, the compounds used
so far have generated several side effects that have limited
their use in SSc. Dipropyltetrasulfide (DPTTS) is a natural
organosulfur compound found in Allium, that is endowed
with pro-oxidative properties and is considered as an anti-
biotic or anti-mitotic agent independently of its effects on
oxidative stress [8,9]. Polysulfides such as DPTTS, are
already considered as a promising new class of antibiotics
for resistant bacteria [10]. In this study, we investigated the
effects of DPTTS on skin fibrosis and immune dysregula-
tions in HOCl-induced SSc in the mouse.
Methods
Animals, chemicals, and procedure
Six-week-old female BALB/c mice were used in all ex-
periments (Harlan, Gannat, France). All mice received
humane care according to our institutional guidelines.
Mice underwent an intradermal injection of 300 μl of a
solution generating HOCl into their back every day for
6 weeks. The same number of mice received PBS under
the same conditions and times as controls. One week after
injection, the animals were killed by cervical dislocation.
Serum and tissue samples were collected from each
mouse and stored at −80°C until use. This study was con-
ducted in compliance with approved animal experimental
procedure number 11-32/11-33, accorded by the French
Comité d'Ethique en Matière d'Expérimentation Animale
Paris Descartes (CEEA 34).
HOCl was produced by adding 166 μl of NaClO solu-
tion (9.6% as active chlorine) to 11.1 ml of KH2PO4 so-
lution (100 mM (pH 6.2)) (16). The HOCl concentration
was determined by spectrophotometry at 280 nm (molar
absorption coefficient = 350 μM//cm) The optical density
(OD) at 280 nm was adjusted to 0.7 to 0.9, and the
amount of sodium hypochlorite and/or KH2PO4 solution
was adjusted to retain the optimal HOCl concentration
generated, based on the OD. All cells were cultured as
reported previously [7]. All chemicals were from Sigma-
Aldrich (France), if not specified.
Synthesis of dipropyltetrasulfide
Dipropyltetrasulfide (DPTTS) was synthesized from pro-
pylmercaptan and sulfur chloride (S2Cl2). A solution of
10 mM propylmercaptan and 10 mM pyridine in 25 mlanhydrous diethyl ether was stirred at −78°C. A solution
of 10 mM sulfur monochloride in 50 ml anhydrous diethyl
ether was added dropwise over a period of 0.5 hours. The
reaction mixture was stirred for an additional 0.5 hours,
and another solution of 10 mM propylmercaptan and
10 mM pyridine in 25 ml anhydrous diethyl ether was
added dropwise over a 0.5–hour period. The reaction mix-
ture was stirred for an additional hour. The reaction was
stopped by adding 25 ml of H2O. The mixture was brought
to room temperature, and then adjusted with 0.5M NaOH
until the pH was neutral, pH 7. The organic phase was
dried over MgSO4, filtered, and evaporated to yield a yel-
low oil with a strong onion smell. DPTTS was purified
with column chromatography by using petrol ether:chloro-
form (95:3) as eluent. Characterization of the compound
was carried out by NMR (Bruker Rheinstetten) type DRX
500 and Avance 500); 1H NMR (500 MHz, CDCl3): δ1.02
(6H, t, J = 7.4 Hz), 1.79 (m, 4H), 2.91(4H, t, J = 7.4 Hz). The
molecular mass was confirmed by GC-MS, and purity was
confirmed with HPLC. The MS values obtained were m/z
214 (M+), 184, 150, and 75 [11].
Isolation of fibroblasts from the skin of mice
At the time of death, skin fragments were collected
from HOCl-treated mice or PBS-treated mice. The frag-
ments of skin were digested with “liver digest medium”
(Invitrogen) for 1 hour at 37°C. After three washes, iso-
lated cells were seeded into sterile flasks, and isolated
fibroblasts were cultured in DMEM/Glutamax-I sup-
plemented with 10% heat-inactivated fetal calf serum
and antibiotics at 37°C in humidified atmosphere with
5% CO2, as previously described [7].
H2O2 production and levels of intracellular reduced
glutathione
The 4 × 104 cells/well of isolated normal and HOCl- fi-
broblasts were coated in 96-well plates (Costar) and in-
cubated for 48 hours at 37°C with either medium alone
or with 2.5, 5, 10, 20, or 40 μM DPTTS. Levels of H2O2
and GSH were assessed spectrofluorometrically (Fusion;
Perkin Elmer, Wellesley, MA, USA) by using 2′, 7′-
dichlorodihydrofluorescein diacetate (H2DCFDA) and
monochlorobimane, respectively. Here, cells were incu-
bated with 200 μM H2DCFDA for 1 hour or 50 μM
monochlorobimane in PBS for 15 minutes at 37°C. Intra-
cellular H2O2 and GSH levels were expressed as arbitrary
units of fluorescence intensity referred to the number of
viable cells as assessed with the Crystal Violet assay.
Modulation of H2O2 metabolism in normal and SSc
fibroblasts
Isolated primary fibroblasts (2 × 104 cells/well) from nor-
mal and HOCl mice were seeded in 96-well plates and
incubated for 12 hours in complete medium alone or
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(NAC, a GSH precursor), 1.6 mM BSO (GSH inhibitor),
20 U PEG-catalase, 400 μM aminotriazol, catalase inhibi-
tor), or 8 μM diethyldithiocarbamate (DDC, superoxide
dismutase inhibitor). DPTTS (30 μM) was added during
the last 16 hours. Cells were then washed 3 times with
PBS and incubated with 100 μl per well of 200 μM
H2DCFDA for 30 minutes. Intracellular H2O2 levels
were expressed as described earlier.
In vitro cell-proliferation and viability assays
Isolated normal and HOCl fibroblasts (4 × 103 cells/well)
(Costar) were incubated in 96-well plates with complete
medium and various doses of DPTTS (10 to 40 μM) for
48 hours at 37°C. Cell proliferation was determined by
pulsing the cells with [3H]thymidine (1 μCi/well) during
the last 16 hours of culture, as previously described [7].
Cell viability was evaluated with the CV assay [12]. Results
are expressed as percentages of viable treated cells versus
viable untreated cells.
Fluorescence-activated cell-sorting analysis of cell death
Apoptosis and necrosis were analyzed with the fluorescence-
activated cell-sorting (FACS) Canto II flow cytometer
(Becton Dickinson), by using the Membrane Permeability/
Dead Cell Apoptosis Kit with YO-PRO-1 and propidium
iodide (PI) for flow cytometry (Invitrogen), according to
the manufacturer’s recommendations. In brief, isolated
normal and HOCl fibroblasts (1.2 × 104) were incu-
bated with 40 μM DPTTS for 5, 10, 15, or 24 hours.
After the incubation period, cells were collected, washed
2 times with PBS, stained for 10 minutes on ice with
1.5 μM PI and 0.1 μM YO-PRO-1, and analyzed with flow
cytometry.
Dermal thickness
Skin thickness was measured on the backs of the mice
in the area of intradermal injections 1 day before killing.
Dermal thickness was measured with a caliper and
expressed in millimeters [7].
Measurements of collagen content in skin and lung
Skin was taken with a punch (6 mm diameter), and lung
pieces were diced using a sharp scalpel, mixed with pep-
sin (1:10 weight ratio) and 0.5M acetic acid at room
temperature. After 3 days, collagen content was assayed
by using the quantitative dye-binding Sircol method
(Biocolor, Belfast, N. Ireland) [13,14].
Ex vivo skin fibroblast proliferation
Primary normal and HOCl fibroblasts from HOCl mice
or PBS mice treated or not with DPTTS (4 × 103 cells/
well) (Costar; Corning, Inc., Corning, NY, USA) were in-
cubated in 96-well plates with complete medium, for48 hours at 37°C. Cell proliferation was determined by
pulsing the cells with [3H]thymidine (1 μCi/well) during
the last 16 hours of culture, as described earlier.
Histopathologic analysis
A 5-μm-thick tissue section was prepared from the mid-
portion of paraffin-embedded skin and lung pieces and
stained with hematoxylin/eosin. Slides were examined with
standard bright-field microscopy (Olympus BX60) by a path-
ologist who was blinded to the assignment of the animal.
Analysis of α-SMA and pSmad2/3 expression in mouse
skin
Expression of α-SMA and pSmad2/3 was analyzed with
immunohistochemistry of skin fragments derived from
HOCl and PBS mice treated or not with DPTTS. Tissue
sections were deparaffinized and rehydrated, and then
incubated with 200 μg/ml proteinase K for 15 minutes
at 37°C for antigen retrieval. Specimens were then
treated with 3% vol/vol H2O2 for 10 minutes at 37°C to
inhibit endogenous peroxidases and then blocked with
BSA 5% wt/vol for 1 hour at 4°C. Sections were incu-
bated with 1:100 anti-α-smooth muscle actin, mAb con-
jugated with alkaline phosphatase (Sigma-Aldrich) and
with a 1:100 mAb directed to phospho-Smad2/3 (Cell
Signaling Technology) for 2 hours at room temperature.
Sections incubated with pSmad2/3 were then incubated
with HRP-conjugated secondary goat anti-rabbit ab
(Rockland) for 1 hour at room temperature. Antibody
binding for αSMA staining was visualised by using nitro-
blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl
phosphate (NBT/BCIP). Staining of pSmad2/3 was vi-
sualized by using diaminobenzidine tetrahydrochloride
(DAB) as a chromogen. The slides were examined with
standard bright-field microscopy (Olympus BX60). Ap-
propriate controls with irrelevant alkaline phosphatase-
conjugated and HRP-conjugated abs were performed.
Determination of advanced oxidation protein product
(AOPP) concentrations in sera
AOPP were measured with spectrophotometry, as previ-
ously described [7]. Calibration used chloramine-T within
the range of 0 to 100Μ.
Detection of serum anti-DNA topoisomerase-1 IgG Abs
Serum levels of anti-DNA topoisomerase-1 IgG abs were
detected with ELISA by using coated DNA topoisomerase-
1 purified from calf thymus (Immunovision). Optical dens-
ity was measured at 405 nm by using a Dynatech MR 5000
microplate reader (Dynex Technology).
Flow-cytometric analysis and splenocyte proliferation
Spleen cell suspensions were prepared after hypotonic lysis
of erythrocytes. Splenocytes (106 cells) were incubated with
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were then analyzed with a FACS Canto flow cytometer
(BD Biosciences). For spleen cell proliferation, B and T
cells were purified with MACS and were coated onto
96-well plates. In brief, splenic B- or T-cell suspen-
sions (2 × 105 cells) were cultured with 10 μg/ml of
LPS (Boehringer, Mannheim, Germany) for B cells, or
with 2.5-μg/ml precoated anti-CD3 and 1-μg/ml pre-
coated anti-CD28 mAbs for T cells. Cell proliferation
was determined as described earlier.
Determination of IL-4 and IL-13
MACS-purified splenic T cells (2 × 105 cells per well)
were cultured in 96-well plates in complete medium for
48 hours at room temperature in the presence of 5 μg/ml
concanavalin A. Cytokines were measured from the
collected supernatants with ELISA (R&D Systems) by
following the manufacturer’s instructions. Determined
concentrations were expressed in nanograms per milliliter.
Statistical analysis
All quantitative data were expressed as mean ± SEM.
Data were compared by using one-way ANOVA plus the
Tukey test for the comparison of means among multiple
groups. P value of <0.05 was considered significant.a
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Figure 1 Effect of DPTTS on normal fibroblasts and fibroblasts from H
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(e) and viability (F) were determined as expressed earlier. Results are given
**P < 0.01; ***P < 0.001.Results
DPTTS exerted in vitro antiproliferative and cytotoxic
effects on normal and HOCl fibroblasts
Fibroblasts from normal and HOCl mice were exposed
in vitro to increasing amounts of DPTTS (10 μM to
40 μM). The proliferative rates of HOCl fibroblasts were
62.9% ± 4.2% and 5.1% ± 0.5% in the presence of 10 μM
and 40 μM DPTTS, respectively. These rates were lower
than those found for PBS-fibroblasts under the same con-
ditions (82.4 ± 1.4%, P < 0.01 and 61.1 ±4.8, P < 0.001).
Thus DPTTS exerted a stronger antiproliferative effect on
HOCl fibroblasts than on normal fibroblasts (Figure 1a).
Similarly the cytotoxic effects of DPTTS were higher
against HOCl fibroblasts than against normal fibro-
blasts, because the viability rates of HOCl fibroblasts
were 66.1% ± 2.2% and 8.6% ± 4.7% in the presence of
10 μM and 40 μM DPTTS, respectively, versus 84.3% ±
9.5%; P < 0.05; and 69.4% ± 1.1% (P < 0.001) under the
same conditions (Figure 1b).
DPTTS exerted prooxidative effects in vitro
The basal production of H2O2 was increased by 39% in
HOCl fibroblasts compared with normal fibroblasts (4,285
A.U. ± 241 versus 2,658 A.U. ± 235; P < 0.05; Figure 1c).
Incubation of normal fibroblasts with DPTTS did note
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per group) were seeded in a 96-well plate in triplicates (2 × 104/well)
urs and exposed to DPTTS for 16 hours. Production of ROS (H2O2)
as the mean ± SEM of three independent experiments. *P < 0.05;
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DPTTS dose-dependently increased the production of
H2O2 by HOCl fibroblasts (8,595 A.U. ± 269 versus 4,285
A.U. ± 241; P < 0.001, with 40 μM DPTTS; Figure 1c).
We also investigated the effects of DPTTS on the level of
reduced glutathione (GSH), an essential substrate involved
in H2O2 catabolism. The basal level of reduced GSH was
decreased by 166% ± in HOCl fibroblasts compared with
normal fibroblasts (−132 A.U. ± 43.8 versus 380 A.U. ±
22.6; P < 0.001, Figure 1d). The level of intracellular gluta-
thione was significantly higher (P < 0.001) in normal fibro-
blasts than in HOCl fibroblasts in the presence of DPTTS
at all tested doses (Figure 1d).
Modulation of H2O2 metabolism in SSc fibroblasts
We next investigated the mechanism of action of DPTTS
by using specific modulators of oxidative stress. PBS or
HOCl fibroblasts were incubated with or without DPTTS
in the presence of NAC, BSO, catalase, AT, or DDC. Coin-
cubation of DPTTS with NAC, a precursor of GSH,
significantly decreased H2O2 production by 57% in PBS
fibroblasts and by 60% in HOCl fibroblasts (P < 0.05 for
normal and P < 0.01 for HOCl fibroblasts, Figure 1e).
Hydrogen peroxide is converted into H2O by catalase and
the GSH/GPx complex. Depleting GSH with BSO signifi-
cantly increased H2O2 production by 30% in HOCl fibro-
blasts (P < 0.05) and by 31% in PBS fibroblasts (P < 0.05).
In addition, H2O2 production by HOCl fibroblasts coincu-
bated with DPTTS and BSO reached 7.92 ± 0.4 A.U. com-
pared with those incubated with BSO alone (5.48 ± 0.08
A.U.) or DPTTS alone (3.15 ± 0.3 A.U.), showing the
additive effect of DPTTS and BSO (P < 0.05). Conversely,
addition of DPTTS in the presence of the catalase inhibi-
tor ATZ or with exogenous PEG-catalase or with the
superoxide dismutase inhibitor DDC had no effect on the
levels of H2O2 in normal and HOCl fibroblasts (Figure 1e).
Depleting GSH by adding BSO to the culture medium
with DPTTS significantly decreased the viability of HOCl
fibroblasts (P < 0.01). In contrast, specific inhibition of
catalase by ATZ or of superoxide dismutase by DDC had
no effect on the viability of normal and HOCl fibroblasts
(Figure 1f).
DPTTS-induced apoptosis in PBS and HOCl fibroblasts
Fibroblasts extracted from the skin of PBS and of HOCl
mice were incubated with 10, 20, and 40 μM DPTTS
for 5, 10, 15, or 24 hours. The highest level of cytotoxicity
was observed with 40 μM DPTTS. After 15 hours at
this concentration, the viability was decreased by 38%
in HOCl fibroblasts and by 14% in PBS fibroblasts (P <
0.001; Figure 2a). A kinetic analysis of cell death be-
tween 5 and 24 hours showed that DPTTS mediated
cell death essentially through an apoptotic process
(Figure 2b).DPTTS decreased skin and lung fibrosis in mice with SSc
HOCl-induced SSc is associated with an increase in
dermal thickness that is significantly reduced by DPTTS
(P < 0.001 versus untreated HOCl mice; Figure 3a). These
results were confirmed by the histopathologic analysis of
the skin of PBS and HOCl mice treated or not with
DPTTS (Figure 3c). In vivo, DPTTS significantly reduced
the accumulation of type I collagen induced by HOCl in
the skin (P < 0.01; Figure 3b) and in the lung (P < 0.05;
Figure 4a) versus untreated HOCl mice. Histopathologic
analysis of lung biopsies stained with hematoxylin and
eosin (Figure 4b) confirmed the reduction in lung fibro-
sis in HOCl mice treated with DPTTS. Moreover, the
ex vivo proliferation rate of fibroblasts isolated from HOCl
mice was significantly reduced by in vivo treatment with
DPTTS (8,729 cpm ± 445 versus 6,842 cpm± 420; P <
0.01; Figure 3d).
DPTTS reduced the expression of αSMA and pSmad2/3 in
HOCl mice
The expression of αSMA was significantly higher in the
skin of HOCl mice than in PBS mice (22.6% ± 1.6% posi-
tive area in HOCl mice versu 10.01% ± 0.8%, in PBS mice;
P < 0.01; Figure 3c). DPTTS decreased the expression of
α-SMA by 40% in HOCl mice (13.7% ± 0.4% positive area
versus 22.6% ± 1.6% positive area in untreated HOCl mice;
P < 0.01; Figure 3c). The level of expression of pSmad 2/3,
a key protein involved in TGF-β-induced fibrogenesis, was
higher in HOCl mice than in PBS controls (24.5% ± 1.4%
positive area in HOCl mice versus 5.8% ± 0.4% positive area
in PBS mice; P < 0.01; Figure 3c). In vivo administration of
DPTTS reduced pSmad2/3 expression in HOCl mice
(7.2% ± 2.1% positive area versus 24.5% ± 1.4% positive
area in untreated HOCl mice; P < 0.01; Figure 3c).
DPTTS decreased the serum concentration of AOPP
and anti-DNA topoisomerase-1 Abs in SSc mice
Advanced oxidation protein products (AOPPs), a marker
of systemic oxidative stress, were increased in the sera
of HOCl mice compared with PBS mice (P < 0.001,
Figure 5a). DPTTS reduced the levels of AOPP by 28%
in HOCl mice versus untreated HOCl mice (P < 0.05;
Figure 5a). The sera of HOCl mice contained significantly
higher levels of anti-DNA-topoisomerase-1 abs than did
the sera from PBS mice (1.96 A.U. ± 0.1 versus 1.39 A.U. ±
0.11; P < 0.05; Figure 5b). DNA-topoisomerase-1 abs were
significantly decreased in the sera from HOCl mice treated
with DPTTS compared with untreated HOCl mice (1.47
A.U. ± 0.09 versus 1.96 A.U. ± 0.1; P < 0.05; Figure 5b).
DPTTS decreased the counts of B cells and the
proliferation rate of B and T cells in HOCl mice
We next tested the effects of DPTTS on spleen cell
populations. Intradermal injection of HOCl significantly
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compared with normal mice (40.3% ± 0.6% versus 34.1% ±
0.61%; P < 0.01; Figure 6a). DPTTS decreased the number
of splenic B cells by 16% in HOCl mice compared with
untreated HOCl mice (34.7% ± 1.1% versus 40.3% ± 0.6%;
P < 0.01; Figure 6a).
We also investigated the proliferation rate of splenic T
cells after stimulation with precoated anti-CD3/CD28
mAb, and of B cells after stimulation with LPS. T and Ba
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ditions (5,538 cpm ± 427 versus 10,967 cpm ± 786; P <
0.001; Figure 6b). B cells isolated from HOCl mice treated
with DPTTS and stimulated with LPS also displayed ac
TT
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treated HOCl mice (7,625 cpm ± 851 versus 12,380 cpm ±
1,572; P < 0.05; Figure 6c).
In vivo administration of DPTTS reduced the production
of IL-4 and IL-13 in HOCl mice
HOCl mice had a higher serum concentration of IL-4
and IL-13 than did PBS-treated mice (1.03 ± 0.09 ng/ml
versus 0.58 ± 0.1 ng/ml; P < 0.01 for IL-4, Figure 6d;
1.2 ± 0.07 ng/ml versus 0.63 ± 0.15 ng/ml; P < 0.01 for
IL-13; Figure 6e). DPTTS decreased the levels of IL-4
in HOCl mice by 37% (P < 0.05; Figure 6d), and of
IL-13 by 36% (P < 0.05; Figure 6e).
Discussion
In the present study, we showed that the natural organo-
sulfur compound, DPTTS, prevents the development of
fibrosis in a murine model of chemically induced sys-
temic sclerosis.
DPTTS is able to increase the intracellular level of
ROS to generate a lethal oxidative burst in fibroblasts
from mice with HOCl-induced SSc. The cytotoxic effecta
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ous reduced GSH and low levels of H2O2. Our results are
in agreement with previous studies on polysulfides show-
ing a prooxidant effect of these molecules. Indeed, in can-
cer cells that constitutively produce high amounts of ROS,
diallyl-polysulfides further increase ROS generation, caus-
ing ß-tubulin oxidation, disruption of the microtubule net-
work, and finally apoptosis [15,16].
Similarly, we showed that the organotelluride catalyst
(PHTE)2NQ and arsenic trioxide molecules that increase
the levels of ROS in activated fibroblasts of HOCl mice
ameliorate the fibrosis in these animals through mechan-
ism similar to that of DPTTS [6,15]. The protective
effects of NAC, a GSH precursor, that neutralizes the
cytotoxicity of DPTTS in HOCl fibroblasts, and the op-
posite effect of BSO, which depletes GSH, emphasize the
role of the GSH pathway in the cytotoxicity of DPTTS.
A paradoxic effect of the prooxidative molecule DPTTS
is the decrease in the serum concentration of AOPP ob-
served in HOCl mice. This can be explained by the select-
ive destruction of diseased fibroblasts, which chronicallyb
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skin, in particular, DNA topoisomerase-1 [7]. Because oxi-
dized DNA topoisomerase-1 is one of the autoantigens
responsible for the breach of tolerance in SSc, DPTTS in-
directly abrogates the autoimmune reaction through the
selective and early destruction of diseased fibroblasts.
DPTTS also downregulates the phosphorylation of
Smad2/3 and contributes to decreasing the accumulation
of type I collagen in the skin of mice with HOCl-induced
SSc. Smad2 and Smad3 are transcription factors that are
overexpressed in human SSc fibroblasts, as well as in
fibroblasts from HOCl mice. Phosphorylated Smad2/3
activates genes coding for type I collagen, which leads
to fibrosis in several organs [15,16]. In addition, TGF-β,
which induces Smad2/3 phosphorylation, is inhibited
by a thiol antioxidant-NAC, GSH, and L-cysteine, thus
highlighting the role of H2O2 in the activation of the
Smad2/3 pathway [17]. Therefore, in HOCl-induced SSc,
the selective depletion of fibroblasts overproducing ROS
by DPTTS decreases the number of cells with high levels
of phosphorylated Smad2/3.
Other features of SSc in patients are an abnormal activa-
tion of immune T and B cells, the presence of inflamma-
tory infiltrates (especially of CD4+ T cells) in the skin and
in the lungs, along with increased levels of various proin-
flammatory and profibrotic cytokines [5,18]. DPTTS exertsan immunoregulatory effect in HOCl mice by limiting the
expansion of B cells, and reducing the hyperproliferation
of CD3/CD28-activated T cells and the proliferation of
LPS-activated B cells. The biologic effect of garlic-derived
organosulfur compounds on leukocytes has been a matter
of controversy. Some reports describe immunostimulatory
properties [19], whereas others highlight cytotoxic effects
on lymphocytes [20] through their prooxidative activity
[19,21]. In our hands, the immunomodulating properties
could be related to the addition of the ROS overproduced
in autoreactive B and T cells and of the ROS induced by
DPTTS, as previously in HOCl mice treated with (PHTE)
2NQ or arsenic trioxide [6,15,22]. The immunomodulatory
properties of DPTTS are also characterized by a decrease
in the splenic production of IL-4 and IL-13 in HOCl mice
treated with this molecule. This effect on profibrotic cyto-
kines, elevated in the skin and in the serum of patients
with SSc [18,23], can explain, at least in part, the antifibro-
tic effects of DPTTS observed in HOCl mice.
Conclusions
DPTTS, an organosulfur compound ubiquitous in plants
of the genus Allium, prevents skin and lung fibrosis in
the mouse through the selective killing of diseased fibro-
blasts. With a mouse model of systemic sclerosis, in vivo
treatment with DPTTS indicates a potential new strategy
Marut et al. Arthritis Research & Therapy 2013, 15:R167 Page 9 of 9
http://arthritis-research.com/content/15/5/R167of treatment of systemic sclerosis. More extensive in vitro
and in vivo studies are now required in human tissues to
evaluate its preclinical applications in connective tissue
disorders.
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